Articles

ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024

ORGS stock results show that Orgenesis missed on revenue for the first quarter of 2024. More 

PPBT Stock Earnings: Purple Biotech Beats EPS for Q1 2024

PPBT stock results show that Purple Biotech beat analyst estimates for earnings per share the first quarter of 2024. More 

MMAT Stock Surges as Lawyers Back Up Naked Shorting Allegations

Meta Materials claims that it has enough evidence of naked short selling. A short squeeze could also be helping MMAT stock. More 

7 Dividend Kings to Buy for Royal Passive Income: May Edition

Fundamentally, the case for dividend kings to buy couldn’t be simpler: investors are banking on the proven stability of the underlying enterprises. Since qualifying for the dividend king title involves providing rising annual payouts for at least 50 consecutive years, you can bet that these companies benefit from reliable businesses. Obviously, this reliability offers much… More 

3 Cathie Wood Stocks to Buy Now: May 2024

Many popular stocks are down, but it may be a mistake to discount these Cathie Wood stocks to buy as new catalysts come to be. More 

Don’t Miss These 3 Tech Rockets With Limitless Upside

High-potential tech stocks should be on every investors' radar as these companies prepare to launch into the next era. More 

3 Reasons Not to Waste Your Time on Apple Stock This Year

Apple's share price may be on the rise, but competitive risk and other unsound fundamentals poise a long-term threat. More 

More Articles
Previous Page